HealthEquity, Inc. (HQY): Price and Financial Metrics
HealthEquity, Inc. (HQY)
Today's Latest Price: $57.66 USD
Updated Oct 23 4:00pm
Add HQY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 9 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
HQY Stock Summary
- The price/operating cash flow metric for Healthequity Inc is higher than 88.98% of stocks in our set with a positive cash flow.
- With a year-over-year growth in debt of 2,677.83%, Healthequity Inc's debt growth rate surpasses 98.96% of about US stocks.
- Revenue growth over the past 12 months for Healthequity Inc comes in at 126.4%, a number that bests 95.55% of the US stocks we're tracking.
- Stocks that are quantitatively similar to HQY, based on their financial statements, market capitalization, and price volatility, are XPER, CREE, KMPH, URG, and ADMP.
- Visit HQY's SEC page to see the company's official filings. To visit the company's web site, go to www.healthequity.com.
HQY Stock Price Chart Interactive Chart >
HQY Price/Volume Stats
| Current price | $57.66 | 52-week high | $88.78 |
| Prev. close | $55.14 | 52-week low | $34.40 |
| Day low | $55.83 | Volume | 754,800 |
| Day high | $58.09 | Avg. volume | 911,548 |
| 50-day MA | $53.98 | Dividend yield | N/A |
| 200-day MA | $58.00 | Market Cap | 4.43B |
HealthEquity, Inc. (HQY) Company Bio
HealthEquity Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company was founded in 2002 and is based in Draper, Utah.
HQY Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $57.66 | $38.09 | -28% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Healthequity Inc. To summarize, we found that Healthequity Inc ranked in the 39th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Healthequity Inc, consider:
- Its compound free cash flow growth rate, as measured over the past 5.45 years, is 0.51% -- higher than 80.45% of stocks in our DCF forecasting set.
- Healthequity Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 11. This value is greater than 88.28% stocks in the Technology sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -30% |
| 1% | -29% |
| 2% | -28% |
| 3% | -28% |
| 4% | -27% |
| 5% | -26% |
ADI, CDK, FIVN, UEIC, and ALRM can be thought of as valuation peers to HQY, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...